key: cord-0889842-nmrxjal1 authors: Lee, Woojong; Kingstad-Bakke, Brock; Kedl, Ross M.; Kawaoka, Yoshihiro; Suresh, M. title: CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus date: 2021-03-25 journal: bioRxiv DOI: 10.1101/2021.03.24.436901 sha: c1047e1e185c9a2aae950b31ef35298c3b88b445 doc_id: 889842 cord_uid: nmrxjal1 Elicitation of lung tissue-resident memory CD8 T cells (TRMs) is a goal of T-cell based vaccines against respiratory viral pathogens such as influenza A virus (IAV). Chemokine receptor 2 (CCR2)-dependent monocyte trafficking plays an essential role in the establishment of CD8 TRMs in lungs of IAV-infected mice. Here, we used a combination adjuvant-based subunit vaccine strategy that evokes multifaceted (TC1/TC17/TH1/TH17) IAV nucleoprotein-specific lung TRMs, to determine whether CCR2 and monocyte infiltration are essential for vaccine-induced TRM development and protective immunity to IAV in lungs. Following intranasal vaccination, neutrophils, monocytes, conventional dendrtitic cells (DCs) and monocyte-derived DCs internalized and processed vaccine antigen in lungs. We also found that Basic Leucine Zipper ATF-Like Transcription Factor 3 (BATF-3)-dependent DCs were essential for eliciting T cell responses, but CCR2 deficiency enhanced the differentiation of CD127HI/KLRG-1LO, OX40+veCD62L+ve and mucosally imprinted CD69+veCD103+ve effector and memory CD8 T cells in lungs and airways of vaccinated mice. Mechanistically, increased development of lung TRMs, induced by CCR2 deficiency was linked to dampened expression of T-bet, but not altered TCF-1 levels or T cell receptor signaling in CD8 T cells. T1/T17 functional programming, parenchymal localization of CD8/CD4 effector and memory T cells, recall T cell responses and protective immunity to a lethal IAV infection were unaffected in CCR2-deficient mice. Taken together, we identified a negative regulatory role for CCR2 and monocyte trafficking in mucosal imprinting and differentiation of vaccine-induced TRMs. Mechanistic insights from this study may aid the development of T-cell-based vaccines against respiratory viral pathogens including IAV and SARS-CoV-2. Importance While antibody-based immunity to influenza A virus (IAV) is type and sub-type specific, lung and airway-resident memory T cells that recognize conserved epitopes in the internal viral proteins are known to provide heterosubtypic immunity. Hence, broadly protective IAV vaccines need to elicit robust T-cell memory in the respiratory tract. We have developed a combination adjuvant-based IAV nucleoprotein vaccine that elicits strong CD4 and CD8 T cell memory in lungs and protects against H1N1 and H5N1 strains of IAV. In this study, we examined the mechanisms that control vaccine-induced protective memory T cells in the respiratory tract. We found that trafficking of monocytes into lungs might limit the development of anti-viral lung-resident memory T cells, following intranasal vaccination. These findings suggested that strategies that limit monocyte infiltration can potentiate vaccine-induced frontline T-cell immunity to respiratory viruses such as IAV and SARS-CoV-2. Elicitation of lung tissue-resident memory CD8 T cells (TRMs) is a goal of T-cell based 22 vaccines against respiratory viral pathogens such as influenza A virus (IAV). Chemokine 23 receptor 2 (CCR2)-dependent monocyte trafficking plays an essential role in the 24 establishment of CD8 TRMs in lungs of IAV-infected mice. Here, we used a combination 25 adjuvant-based subunit vaccine strategy that evokes multifaceted (TC1/TC17/TH1/TH17) 26 IAV nucleoprotein-specific lung TRMs, to determine whether CCR2 and monocyte 27 infiltration are essential for vaccine-induced TRM development and protective immunity to 28 IAV in lungs. Following intranasal vaccination, neutrophils, monocytes, conventional 29 dendrtitic cells (DCs) and monocyte-derived DCs internalized and processed vaccine 30 antigen in lungs. We also found that Basic Leucine Zipper ATF-Like Transcription Factor 31 3 (BATF-3)-dependent DCs were essential for eliciting T cell responses, but CCR2 32 deficiency enhanced the differentiation of CD127 HI /KLRG-1 LO , OX40 +ve CD62L +ve and 33 mucosally imprinted CD69 +ve CD103 +ve effector and memory CD8 T cells in lungs and 34 airways of vaccinated mice. Mechanistically, increased development of lung TRMs, 35 induced by CCR2 deficiency was linked to dampened expression of T-bet, but not altered 36 TCF-1 levels or T cell receptor signaling in CD8 T cells. T1/T17 functional programming, 37 parenchymal localization of CD8/CD4 effector and memory T cells, recall T cell responses 38 and protective immunity to a lethal IAV infection were unaffected in CCR2-deficient mice. 39 Taken together, we identified a negative regulatory role for CCR2 and monocyte To protect individuals from respiratory pathogens such as influenza A viruses (IAV) and 87 SARS-CoV-2, vaccines need to engender balanced humoral and T cell-mediated 88 immunity (21) (22) (23) (24) (25) (26) . While establishment of lung TRMs is likely one of the major goals of 89 designing effective T cell-based vaccines against respiratory pathogens, it has been 90 challenging to elicit durable and effective mucosal T-cell immunity in the lungs using 91 currently available vaccine platforms (27, 28) . While many of the current FDA-approved Understanding key cellular interactions that regulate the generation and persistence of 102 memory T cell subsets is vital for designing effective vaccines. Several factors govern the 103 development of CD8 TRMs following an infection and the roles of regulatory cytokines (e.g. IL-15, and TGF-β) and antigenic stimulation have been extensively investigated in recent 105 years (10, 29-33). There is good evidence that pulmonary monocytes interact with effector 106 CD8 T cells in the lung to drive TRM differentiation following vaccinia or influenza infection 107 (34, 35), but the underlying mechanisms are unknown. Further, it is unclear whether 108 cellular and molecular factors that regulate TRM formation during a viral infection play 109 similar roles in the development of TRMs following vaccination. Given the importance of 110 TRM for protective immunity against respiratory viruses, it is important to elucidate whether 111 monocytes play an important role in engendering T cell immunity following vaccination. Insights from such studies might aid in the rational development of adjuvants that can 113 drive potent vaccine-induced T cell responses by engaging monocytes in the lungs. green + /red + cells were highest at day 2, but dwindled by day 8 after vaccination. At days 172 2 and 5 after vaccination, neutrophils, monocytes and monocyte-derived DCs constituted 173 a major proportion of cells containing processed OVA in lungs ( Figure 1C) . Notably, 174 between days 2 and 8 after vaccination, the percentages of processed DQ-OVA-bearing 175 CD103 +ve migratory DCs increased both in the lungs and draining lymph nodes. By day 176 8, DQ-OVA was predominantly detected in CD103 +ve DCs in DLNs ( Figure 1D ). in CCR2-/-mice 295 296 As an index of effector differentiation, we measured granzyme B levels in NP366-specific 297 effector CD8 T cells in lungs of vaccinated WT and CCR2 -/mice, at day 8 after booster 298 vaccination. Expression of granzyme B in NP366-specific CD8 T cells was not 299 significantly different (P<0.05) in lungs of vaccinated WT and CCR2 -/mice ( Figure 4A ). 300 We have previously reported that vaccination with ADJ+GLA+NP fostered a functionally It is also noteworthy that CCR2 deficiency was associated with increased levels of less Tissue processing and flow cytometry. Lungs and draining lymph nodes were processed using standard collagenase-based 719 digestion, as previously described (40) Tetramer Core Facility for providing MHC-I and MHC-II 777 tetramers. Many thanks to Dr. Lisa Arendt for providing CCR2 -/-strains to initiate this 778 project. We would also like to thank genuine appreciation for the efforts of the veterinary 779 and animal care staff at This work was supported by PHS grant U01 AI124299 Woojong Lee was supported by a predoctoral 784 fellowship from the Author contributions designed, performed, analyzed experiments, and provided conceptual 788 input for the manuscript. Y.K and R.K provided critical reagents for the manuscript. W.L 789 and M.S wrote the manuscript Dendritic cells and the control of immunity The dendritic cell populations of mouse lymph nodes Life cycle, migration and antigen presenting functions of spleen 801 and lymph node dendritic cells: limitations of the Langerhans cells paradigm Respiratory dendritic cell subsets differ in their capacity to support the 804 induction of virus-specific cytotoxic CD8+ T cell responses 806 CXCR3 directs antigen-specific effector CD4+ T cell migration to the lung during parainfluenza virus 807 infection Production of IL-10 by CD4(+) regulatory T cells during the resolution of infection promotes 810 the maturation of memory CD8(+) T cells 812 Resident memory CD8(+) T cells in the upper respiratory tract prevent pulmonary influenza virus 813 infection Pulmonary antigen encounter regulates the establishment of tissue-resident CD8 memory T cells in the 816 lung airways and parenchyma TNF/iNOS-producing dendritic cells are the necessary evil of lethal 819 influenza virus infection Tissue-Resident T Cells and Other Resident Leukocytes Location, location, location: Tissue resident memory T cells in 823 mice and humans Balancing Immune Protection and Immune Pathology by CD8(+) T-Cell 825 Responses to Influenza Infection Retrograde migration supplies resident memory T cells to lung-draining LN 828 after influenza infection Editorial: Pulmonary resident memory CD8 T cells: here today, 830 gone tomorrow Lung airway-surveilling CXCR3(hi) memory CD8(+) T cells 832 are critical for protection against influenza A virus Dynamics of 834 influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity Lung-resident memory CD8 T 837 cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8 T 841 Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis Phenotypic and 844 Functional Alterations in Circulating Memory CD8 T Cells with Time after Primary Infection Activation 847 phenotype, rather than central-or effector-memory phenotype, predicts the recall efficacy of memory 848 CD8+ T cells Establishment and Maintenance of Conventional and Circulation-850 Driven Lung-Resident Memory CD8(+) T Cells Following Respiratory Virus Infections The Way Forward: Potentiating Protective Immunity to Novel and Pandemic Influenza 853 Through Engagement of Memory CD4 T Cells Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-857 Cell Influenza Vaccines The known unknowns of T cell immunity to COVID-19 Human CD8(+) T cell cross-reactivity across influenza A, B and C viruses 864 Accelerating next-generation vaccine development for global disease prevention License to kill: Formulation requirements for optimal priming of 867 CD8(+) CTL responses with particulate vaccine delivery systems CCR7 expression alters memory CD8 T-cell homeostasis 871 by regulating occupancy in IL-7-and IL-15-dependent niches Stromal cells control the epithelial residence of DCs and memory T 875 cells by regulated activation of TGF-beta Environmental 877 and antigen receptor-derived signals support sustained surveillance of the lungs by pathogen-specific 878 cytotoxic T lymphocytes Residual antigen presentation after 880 influenza virus infection affects CD8 T cell activation and migration Inflammatory monocytes contribute 882 to the persistence of CXCR3(hi) CX3CR1(lo) circulating and lung-resident memory CD8(+) T cells following 883 respiratory virus infection Pulmonary monocytes interact with effector T cells in the lung tissue to drive 886 TRM differentiation following viral infection Physico-chemical and bioadhesive properties of polyacrylic acid 888 polymers Characterization of protective immune response elicited by a trimeric envelope protein from an Indian 891 clade C HIV-1 isolate in rhesus macaques Carbomer-based adjuvant elicits CD8 T-cell immunity by inducing a distinct metabolic 894 state in cross-presenting dendritic cells Programming Multifaceted Pulmonary T Cell Immunity by Combination Adjuvants. 900 Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not 903 antibody responses, through a RIPK3-dependent pathway Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in 906 cytotoxic T cell immunity Cutting edge: 908 intravascular staining redefines lung CD8 T cell responses Cell Factor 1 Suppresses CD103+ Lung Tissue-Resident Memory T Cell Development. 911 Cell Rep Understanding Subset Diversity in T Cell Memory T-box Transcription Factors Combine with the Cytokines TGF-beta and IL-15 to 916 Control Tissue-Resident Memory T Cell Fate CD8(+) resident memory T cells balance immunity and fibrotic sequelae T cell 920 receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent 921 reporter mouse Differential response of respiratory dendritic cell subsets to influenza 923 virus infection Principles underlying rational design of live attenuated influenza vaccines Transcriptional profiling reveals functional dichotomy between 928 human slan(+) non-classical monocytes and myeloid dendritic cells Protective T cell immunity in mice following protein-TLR7/8 agonist-931 conjugate immunization requires aggregation, type I IFN, and multiple DC subsets Dendritic cell subsets require cis-activation for cytotoxic CD8 T-cell induction Ly6C(+) monocyte efferocytosis and cross-presentation of cell-associated antigens Monocytes Acquire the Ability to Prime Tissue-Resident T Cells via IL-10-Mediated TGF-941 beta Release Recruited inflammatory monocytes stimulate antiviral Th1 943 immunity in infected tissue Dendritic cell-induced memory T 945 cell activation in nonlymphoid tissues CCR2 947 deficiency promotes exacerbated chronic erosive neutrophil-dominated chikungunya virus arthritis Peripheral blood and airway tissue expression of 950 transforming growth factor beta by neutrophils in asthmatic subjects and normal control subjects Production of transforming growth factor beta by human 953 peripheral blood monocytes and neutrophils Tissue-resident memory T cells: local specialists in immune defence Migratory DCs activate TGF-beta to precondition naive CD8(+) T cells for tissue-resident 958 memory fate 774 We thank Autumn Larsen and Daisy Gates for expert technical assistance. We also are 775 thankful to Dr. Chandranaik B. Marinaik for assistance with vaccination. We gratefully